Therapeutic options in BK virus-associated interstitial nephritis.
Crew
R J
RJ
Division of Nephrology, Columbia University, New York, New York, USA. rc395@columbia.edu
Markowitz
G
G
Radhakrishnan
J
J
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001739:BK Virus; D001706:Biopsy; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation; D009395:Nephritis, Interstitial / Q000473:pathology / Q000821:virology*; D027601:Polyomavirus Infections / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D011183:Postoperative Complications / Q000473:pathology / Q000821:virology; D014412:Tumor Virus Infections / Q000150:complications* / Q000188:drug therapy / Q000473:pathology
D000998:Antiviral Agents; D007166:Immunosuppressive Agents